A Pharmacodynamic Turnover Model Capturing Asymmetric Circadian Baselines of Body Temperature, Heart Rate and Blood Pressure in Rats: Challenges in Terms of Tolerance and Animal-handling Effects

By Sällström Björn   Visser Sandra   Forsberg Tomas   Peletier Lambertus   Ericson Ann-Christine   Gabrielsson Johan  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 32, Iss. 5-6, 2005-12 ,pp. : 835-859

Springer Publishing Company

Access to resources Recommend Favorite

P-Glycoprotein Induction and Tumor Cell-Kill Dynamics in Response to Differential Doxorubicin Dosing Strategies: A Theoretical Pharmacodynamic Model

By Luu Kenneth T.   Uchizono James A.  

Pharmaceutical Research, Vol. 22, Iss. 5, 2005-05 ,pp. : 710-715

Springer Publishing Company

Access to resources Recommend Favorite

Population pharmacodynamic model of the longitudinal FEV₁ response to an inhaled long-acting anti-muscarinic in COPD patients

By Wu Kai   Looby Michael   Pillai Goonaseelan   Pinault Gregory   Drollman Anton   Pascoe Steve  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 38, Iss. 1, 2011-02 ,pp. : 105-119

Springer Publishing Company

Access to resources Recommend Favorite

An integrated pharmacokinetic–pharmacodynamic model for an Aurora kinase inhibitor

By Kamei Hiroko   Jackson Robert   Zheleva Daniella   Davidson Fordyce  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 37, Iss. 4, 2010-08 ,pp. : 407-434

Springer Publishing Company

Access to resources Recommend Favorite

A pharmacokinetic and pharmacodynamic model for intravenous bisphosphonate (pamidronate) in osteoporosis

By Cremers Serge   Sparidans Rolf   den Hartigh Jan   Hamdy Neveen   Vermeij Pieter   Papapoulos Socrates  

European Journal of Clinical Pharmacology, Vol. 57, Iss. 12, 2002-02 ,pp. : 883-890

Springer Publishing Company

Access to resources Recommend Favorite